TORCH syndrome is a group of infectious diseases that can affect fetal development and result in children born with various pathologies. TORCH stands for Toxoplasmosis, Other (other infections, such as syphilis), Rubella, Cytomegalovirus, and Herpes Simplex Virus. These infections can be transmitted from mother to fetus during pregnancy and can cause serious consequences, such as microcephaly, deafness, developmental disabilities, and other birth defects. Attention to TORCH syndrome has increased in recent decades due to increased awareness of the problems associated with perinatal infections, as well as expanded diagnostic and treatment options.
History of the disease and interesting historical facts
TORCH syndrome was first described in the medical literature in the mid-20th century. However, the individual infections that make it up have been known to mankind for centuries. For example, rubella was described as early as the 18th century, and toxoplasmosis was discovered at the beginning of the 20th century. In the 1950s, there was significant progress in understanding the relationship between infections that occur in pregnant women and their consequences for the health of newborns. One of the most famous cases was the rubella outbreak in the United States in 1964-1965, when thousands of children were born with congenital anomalies. This led to accelerated development of a rubella vaccine and increased monitoring of infections during pregnancy. Interestingly, throughout history, the links between some infections and serious complications in the fetus were not always obvious, which emphasizes the importance of modern diagnostic and preventive methods.
Epidemiology
The epidemiology of TORCH syndrome varies depending on the region and the state of the healthcare system. In developed countries, thanks to vaccination and modern diagnostic methods, the incidence of infections included in the syndrome has been significantly reduced. According to the World Health Organization, in 2020, rubella cases worldwide were less than 10 cases per 1 million live births. At the same time, incipient rubella epidemics have occurred in developing countries where the level of immunization is still insufficient. Toxoplasmosis is a common infection, with its incidence varying from 15% to 80% depending on the country. In addition, cytomegalovirus infection affects about 1% newborns in developed countries and can cause serious health consequences. It should be noted that monitoring these diseases allows us to better understand their prevalence and focus efforts on prevention among pregnant women.
Genetic predisposition to this disease
Although TORCH syndrome is primarily caused by infectious agents, some studies suggest that genetic predisposition may play a role in susceptibility to infection during pregnancy. For example, various mutations in genes associated with the immune response, such as those encoding interleukins and interferons, have been identified that may affect a woman’s ability to fight off these infections. In particular, a 2019 study found that women with certain polymorphisms in the IL-6 gene had an increased risk of developing rubella infection during pregnancy, which in turn increased the risk of transmitting the infection to the fetus. Such findings highlight the importance of genetic factors in assessing the risk of TORCH syndrome and the need for an individualized approach to the management of pregnant women.
Risk factors for the development of this disease
Risk factors that contribute to the development of TORCH syndrome are varied and can be both physical and chemical. The main risk factors include:
- Lack of vaccination against rubella and other infections.
- Contact with infected people or biological fluids (for example, in the case of herpes infection).
- Immunodeficiency conditions, including HIV infection, which can reduce the body's ability to fight infections.
- Nutritional deficiencies that result in deficiencies of vitamins and minerals needed to maintain a healthy immune response.
- Use of alcohol and drugs during pregnancy, which can weaken the immune system and increase susceptibility to infections.
- Maternal age, especially young and older women who may have weakened immune mechanisms.
Some infections that are part of the syndrome, such as toxoplasmosis, may also be preserved in the environment, increasing the risk of infection in conditions of poor sanitation or in case of contact with animals.
Diagnosis of this disease
Diagnosis of TORCH syndrome is an important step in the management of pregnant women and their newborns. The main symptoms that indicate the possible presence of infection in a pregnant woman may include:
- Fever and general malaise;
- Skin rash, especially with rubella;
- swollen lymph nodes.
- Symptoms associated with eye or hearing diseases;
- Developmental abnormalities detected by ultrasound examination.
Laboratory tests are key to accurate diagnosis. These include serologic testing to detect antibodies to TORCH infections. For example, in the case of rubella, the presence of IgM and IgG antibodies is determined, which allows the activity and stage of the infection to be assessed. Radiological tests, such as ultrasound, can detect abnormalities in the fetus. Other tests, such as amniocentesis, can be used to detect infections if genetic abnormalities or infections in the fetus are suspected. Differential diagnosis is necessary to exclude other diseases that may have similar symptoms or manifestations.
Treatment
Treatment for TORCH syndrome depends on the specific infection identified in the pregnant woman or newborn. In general, the following approaches are used:
- General treatment includes bed rest and supportive therapy to boost immunity.
- Pharmacological treatment may include antiviral drugs for herpes infection, such as acyclovir. In the case of toxoplasmosis, pyrimethamine and sulfadiazine may be prescribed.
- Surgical treatment may be indicated in cases of severe fetal developmental abnormalities that may require correction immediately after birth.
- Other treatments include antibiotic therapy for syphilis infection or advice on vaccination for future prevention.
It is important to remember that if an infection is detected early in pregnancy, a more aggressive treatment approach may be required, including the possible use of specific antibodies or infection-fighting antiviral drugs.
List of medications used to treat this disease
Among the drugs used for TORCH syndrome, the following can be distinguished:
- Acyclovir - used to treat herpes infection.
- Pyrimethamine is effective against toxoplasmosis.
- Sulfadiazine - also used for toxoplasmosis.
- Rifampicin - can be used for syphilis.
- Immunoglobulins for the prevention and treatment of certain infections.
These drugs not only help treat active infections, but may also reduce the risk of transmission of infections from mother to fetus.
Disease monitoring
Monitoring of women with TORCH syndrome and their newborns includes checkpoints such as regular examinations, assessment of treatment progress, and observation for possible complications. The prognosis for newborns varies depending on the specific infection and the timing of its diagnosis and treatment. For example, toxoplasmosis and rubella may have a favorable prognosis if treated promptly, while infections such as cytomegalovirus may have a more adverse outcome. Complications include both obstetric problems and developmental consequences for the child, such as psychomotor delay, hearing, or vision impairment.
Age-related features of the disease
TORCH syndrome can manifest itself differently depending on age. In newborns, infections can cause serious consequences, including congenital anomalies. In older children and adults, infections may be clinically mild or not manifest at all, but can be dangerous for pregnant women, causing a risk of transmission of infections to the fetus. In adolescents and young adults, infections can also be activated during periods of decreased immune status. Therefore, the importance of prevention and timely vaccination plays a key role in reducing the likelihood of TORCH syndrome at all stages of life.
Questions and Answers
- How are infections included in TORCH syndrome transmitted? Infections are transmitted through contact with infected people, as well as through body fluids such as blood, saliva and urine.
- Can TORCH syndrome be prevented? Yes, prevention includes vaccination against rubella, monitoring the immune system and careful adherence to hygiene standards.
- What symptoms may indicate TORCH infections in the fetus? The main symptoms include developmental delay, comedonosis, abnormalities of the skull structure, hearing and vision problems.
- What is the importance of early diagnosis of TORCH syndrome? Early diagnosis allows for the necessary treatment and minimizes the risk of complications for mother and child.
- What are the long-term effects of TORCH infections on a newborn? Consequences can range from minor to serious, including developmental delays, hearing and vision impairments, and a number of other complications.
